The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.
Physician re-uses syringes at his Las Vegas endoscopy clinic to save money – nine infections of Hepatitis C conclusively traced back.
Continue reading »Learn more about Merck's investigational, all-oral combination regimen for Hepatitis C, MK-5172/MK-8742, that recently received Breakthrough Therapy designation by the FDA.
Continue reading »Additional clinical studies to assess INO-8000/VGX-6150, a vaccine for Hepatitis C, will also take place in the U.S. beginning in 2014.
Continue reading »Two Hepatitis C drugs the FDA is reviewing have the potential to increase cure rates for the liver virus. Discover more about the experimental medications from Johnson & Johnson and Gilead Sciences, called simeprevir and sofosbuvir.
Continue reading »
Learn more about PositiveSingles.com, an online site where patients with Hepatitis C can cultivate friendships and possibly find love, all while comfortably declaring their status.
Continue reading »
There is a natural approach to recalibrate an underactive thyroid resulting from Hepatitis C combination therapy.
Continue reading »In phase 2 trials, the addition of the drug danoprevir to the current treatment regimen for patients with Hepatitis C showed an 85 percent sustained virologic response rate.
Continue reading »A combination of NS5a and Simeprevir will be used in the treatment of chronic Hepatitis C in patients with compensated liver disease. These trials will prove helpful in future developments.
Continue reading »
Discover how probiotics can minimize the Hepatitis C treatment side effects of fatigue, nausea and low appetite.
Continue reading »Boehringer Ingelheim, a leading pharmaceutical company, along with Presidio Pharmaceuticals, has developed a 12-week interferon-free program with promising results.
Continue reading »Inside you'll discover:
You'll also receive the latest news and information to support liver health.
Rest assured, we will not rent your email to anyone.
You should receive your email with links to the reports shortly. If you do not, please check your spam/junk folder.
If you still haven't received our email after a few minutes, please feel free to contact us.
Close Window
